Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03324984 · ClinicalTrials.gov registry record · Phase 2
1% Chloroprocaine(PF) vs. Bupivacaine Spinals
A Phase 2 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
NCT03324984 is a Phase 2 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 110 participants.
The verdict
NCT03324984, a Phase 2 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
Study Summary
The use of 1% Chloroprocaine (PF) spinal anesthesia will reduce the recovery times and discharge time of patients undergoing hemorrhoidectomies as compared to 0.75% bupivacaine spinal. The primary objective is to compare the recovery times (return of motor and sensory function) and discharge time (voiding time) between 2-Chloroprocaine and 0.75% bupivacaine spinal anesthesia for hemorrhoidectomies. This is a randomized, prospective study assigning patients to either 2-Chloroprocaine (PF) or 0.75% bupivacaine spinal anesthesia group.
Interventions
- DRUG 1% chloroprocaine
- DRUG 0.75% bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-09-11 |
| Est. Completion | 2023-02-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03324984
The ClinicalTrials.gov registry entry for NCT03324984 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 1% chloroprocaine is the first listed.
NCT03324984 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03324984 about?
NCT03324984 is a clinical study titled "1% Chloroprocaine(PF) vs. Bupivacaine Spinals". The use of 1% Chloroprocaine (PF) spinal anesthesia will reduce the recovery times and discharge time of patients undergoing hemorrhoidectomies as compared to 0.75% bupivacaine spinal. The primary objective is to compare the recovery times (return of motor and sensory function) and discharge time (v...
What is the current status of trial NCT03324984?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2019-09-11. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT03324984?
The interventions under investigation include: 1% chloroprocaine (DRUG), 0.75% bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03324984?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.